Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism.
It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases.
Agios Pharmaceuticals, Inc. was formerly known as CANCER METABOLISM THERAPEUTICS, INC. and changed its name to Agios Pharmaceuticals, Inc. in April 2008. The company is based in Cambridge, Massachusetts.
Current Team (12)Update
Chief Scientific Officer
VP Business Development & Operations
Director of Human Resources
Chief Operating Officer
Funding Rounds (3) - $86.8MUpdate
Board Members and Advisors (17)Update
Third Rock Ventures invests in transformational life science companies that show high growth...
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
Celgene discovers, develops and commercializes innovative therapies to treat cancer and...
38 Sidney Street
Cambridge, MA 02139